Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric epithelial glycolipid receptors are a diverse group of carbohydrate-containing lipids located on the apical surface of the gastric mucosa that serve as critical attachment sites for pathogens. These receptors include neutral glycolipids such as Lewis b (Leb) and H-type 1 antigens, as well as acidic glycolipids like sulfatides and sialyl-Lewis x (sLex) (Borén et al., 1993; Saitoh et al., 1991). Their primary biological function in the context of human disease is to facilitate the adhesion of Helicobacter pylori via bacterial adhesins like BabA and SabA, which is a prerequisite for persistent colonization and subsequent mucosal injury (Mahdavi et al., 2002). This interaction is a key driver in the pathogenesis of chronic gastritis, peptic ulcer disease, and gastric malignancies, including adenocarcinoma and MALT lymphoma. Therapeutic interventions targeting these receptors focus on anti-adhesive strategies, such as the use of carbohydrate mimetics or competitive inhibitors like 3'-sialyllactose to prevent bacterial docking (Simon et al., 1997). Additionally, gastroprotective agents like rebamipide have been shown to modulate the composition and protective function of these glycolipids, enhancing the gastric mucosal barrier against injury (Naito et al., 2010).
Inhibition of bacterial adhesion to the gastric mucosa through competitive binding or modulation of receptor expression.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric epithelial glycolipid receptors.